DZ Bank
CRSP icon

DZ Bank’s CRISPR Therapeutics CRSP Stock Holding History

DZ Bank’s Portfolio CRSP Stock Details CRSP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-460
Closed -$21.6K – 963
2024
Q3 		$21.6K Buy
+460
New +$23.3K ﹤0.01% 953
2022
Q1 		– Sell
-183,558
Closed -$14.5M – 999
2021
Q4 		$14.5M Hold
183,558
– – 0.02% 313
2021
Q3 		$20.5M Hold
183,558
– – 0.03% 273
2021
Q2 		$29.7M Hold
183,558
– – 0.05% 220
2021
Q1 		$22.4M Buy
+183,558
New +$27.7M 0.04% 241

Other funds holding CRSP

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $564B AUM 30.12% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return